Acupuncture Versus Sham for Radiotherapy-Induced Emesis
Acupuncture Compared To Sham With a Placebo-Needle in Radiotherapy-Induced Nausea - a Randomised Controlled Study
3 other identifiers
interventional
237
1 country
1
Brief Summary
The aim of this study is to evaluate if acupuncture prevents or reduces nausea or vomiting during radiotherapy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2004
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2007
CompletedFirst Submitted
Initial submission to the registry
February 11, 2008
CompletedFirst Posted
Study publicly available on registry
February 22, 2008
CompletedFebruary 22, 2008
November 1, 2007
3.2 years
February 11, 2008
February 21, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients with at least one episode of nausea during the whole radiotherapy treatment period
The radiotherapy treatment period (md 5 weeks)
Secondary Outcomes (1)
Secondary outcome measures are the summed number of days with nausea, intensity of nausea, number of patients and summed number of days with vomiting, belief in the antiemetic effects and interest in receiving needling in the future
From acupunture start until 4 weeks after treatment stopped
Study Arms (2)
Acupuncture
EXPERIMENTALSham
PLACEBO COMPARATORInterventions
Acupuncture was administered bilaterally to the standard antiemetic point2-4 pericardium six (PC6) located between the tendons of palmaris longus and flexor carpii radialis at two body-inches proximal of the wrist crease. Sharp needles, diameter 0.25 x length 40 millimetres, were inserted into a depth of a half body-inch. One body-inch (or a "cun" in traditional Chinese medicine context) is equivalent to the greatest width of the individual patients´ thumb at the distal phalanx, approximately one and a half centimetres or one American thumb. The needles were manipulated three times (at the start, middle and end of the treatment session) by twirling, thrusting and lifting until deqi occurred.
Sham acupuncture was administered bilaterally to a non-acupuncture point two body-inches proximal of PC6 with the telescopic Park sham device16, 0.30 x 40 millimetres (fully extended length). That needle looks identical with a real needle but is blunted and glides upwards into its handle instead of penetrating, which gives an illusion of penetration. The marking tubes hold the needles in place. The therapist gave an illusion of manipulation by turning the needle three times, each time for a couple of seconds until the needle touched the skin, but no deqi occurred. Except when placing and manipulating the sham needle, it was not pressed against the skin at all.
Eligibility Criteria
You may qualify if:
- patients of at least 18 years of age
- with gynaecologic-, anal-, rectal-, colon-, ventricle-, pancreatic- or testicular tumours
- willing to give their informed consent
- able to take part in the entire treatment and data collection procedure
- had planned radiation over an abdominal and/or pelvic field (with or without concomitant chemotherapy) with the volume of at least 800 cm3 and a dose of at least 25 Gy.
You may not qualify if:
- use of antiemetic treatment or persistent nausea within 24 hours prior to the start of radiotherapy
- ever received acupuncture against nausea, or during the last year received acupuncture for any indication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Linkoepinglead
- Swedish Cancer Societycollaborator
- Ostergotland County Council, Swedencollaborator
- Vardalinstitutet The Swedish Institute for Health Sciencescollaborator
- Cancer & Traffic Injury Fundcollaborator
Study Sites (1)
Sussanne Börjeson
Linköping, 58185, Sweden
Related Publications (3)
Efverman A, Kristofferzon ML. A Basis for Strengthening Coping Strategies and Treatment Expectations in Patients Undergoing Emetogenic Pelvic-Abdominal Radiotherapy: A Longitudinal Study. Integr Cancer Ther. 2024 Jan-Dec;23:15347354241281329. doi: 10.1177/15347354241281329.
PMID: 39300870DERIVEDBlom K, Efverman A. Sleep During Pelvic-Abdominal Radiotherapy for Cancer: A Longitudinal Study With Special Attention to Sleep in Relation to Nausea and Quality of Life. Cancer Nurs. 2021 Jul-Aug 01;44(4):333-344. doi: 10.1097/NCC.0000000000000826.
PMID: 32371667DERIVEDEnblom A, Lekander M, Hammar M, Johnsson A, Onelov E, Ingvar M, Steineck G, Borjeson S. Getting the grip on nonspecific treatment effects: emesis in patients randomized to acupuncture or sham compared to patients receiving standard care. PLoS One. 2011 Mar 23;6(3):e14766. doi: 10.1371/journal.pone.0014766.
PMID: 21448267DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sussanne Börjeson, PhD
Linkoeping University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 11, 2008
First Posted
February 22, 2008
Study Start
January 1, 2004
Primary Completion
March 1, 2007
Study Completion
March 1, 2007
Last Updated
February 22, 2008
Record last verified: 2007-11